Avenue Biosciences

Avenue Biosciences develops a protein engineering platform that utilizes machine learning and synthetic biology to optimize the secretory pathway for therapeutic protein manufacturing. The technology analyzes thousands of signal peptides to enhance production yields and quality for biologics, biosimilars, and cell and gene therapies. The company serves biotechnology firms and therapeutic developers by reducing production costs and time-to-market for difficult-to-express proteins.